In Silico and In Vitro Development of novel small interfering RNAs (siRNAs) to inhibit SARS-CoV-2 DOI Creative Commons
Noha Samir Taibe, Sara H. Mahmoud,

Maimona A. Kord

et al.

Computational and Structural Biotechnology Journal, Journal Year: 2025, Volume and Issue: unknown

Published: March 1, 2025

Language: Английский

Testing for SARS-CoV-2: lessons learned and current use cases DOI
Elitza S. Theel, James E. Kirby, Nira R. Pollock

et al.

Clinical Microbiology Reviews, Journal Year: 2024, Volume and Issue: 37(2)

Published: March 17, 2024

SUMMARY The emergence and worldwide dissemination of SARS-CoV-2 required both urgent development new diagnostic tests expansion testing capacity on an unprecedented scale. rapid evolution technologies that allowed to move out traditional laboratories into point-of-care centers the home transformed landscape. Four years later, with end formal public health emergency but continued global circulation virus, it is important take a fresh look at available consider how they should be used going forward. This review considers current use case scenarios for antigen, nucleic acid amplification, immunologic tests, incorporating latest evidence analytical/clinical performance characteristics advantages/limitations each test type inform debates about or not used.

Language: Английский

Citations

6
In Silico and In Vitro Development of novel small interfering RNAs (siRNAs) to inhibit SARS-CoV-2 DOI Creative Commons
Noha Samir Taibe, Sara H. Mahmoud,

Maimona A. Kord

et al.

Computational and Structural Biotechnology Journal, Journal Year: 2025, Volume and Issue: unknown

Published: March 1, 2025

Language: Английский

Citations

0